Cargando…
Hepatocellular Senescence: Immunosurveillance and Future Senescence-Induced Therapy in Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related deaths worldwide. The lack of effective targeted drugs has become a challenge on treating HCC patients. Cellular senescence is closely linked to the occurrence, development, and therapy of tumor. Induction of cellular senesc...
Autores principales: | Liu, Peng, Tang, Qinghe, Chen, Miaomiao, Chen, Wenjian, Lu, Yanli, Liu, Zhongmin, He, Zhiying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732623/ https://www.ncbi.nlm.nih.gov/pubmed/33330071 http://dx.doi.org/10.3389/fonc.2020.589908 |
Ejemplares similares
-
Pro-senescence therapy for hepatocellular carcinoma
por: Muehlich, Susanne, et al.
Publicado: (2013) -
Cellular senescence enhances adaptive anticancer immunosurveillance
por: Marin, Ines, et al.
Publicado: (2022) -
Immunosurveillance of senescent cancer cells by natural killer cells
por: Iannello, Alexandre, et al.
Publicado: (2014) -
Roles of eIF5A in the immunosurveillance of cellular senescence
por: Jiang, Xiangli, et al.
Publicado: (2022) -
Biomarkers and Future Perspectives for Hepatocellular Carcinoma Immunotherapy
por: He, Yuqing, et al.
Publicado: (2021)